BIRMINGHAM, Alabama (January 27, 2022)—The Food and Drug Administration has expanded Philips Respironics’ product recall, adding the Trilogy Evo ventilator and muffler repair kits to the list—and declared it a level 1 recall, the most severe.
Respiratory
Recalls, reimbursement, remote data & referrals all changing the landscape
HME providers, industry working out impacts of Philips device recall
Survey reveals patients are ready to take on treatment via telehealth
9 ways to save money & staff time while keeping your inventory healthy & ready for use
How manufacturers & others are stepping up
Editor's Note: Updated May 1, 2020 with additional information.
BIRMINGHAM, Alabama (January 30, 2020)—The introduction of several new CPAP masks over the past 15 months helped drive strong earnings for ResMed, the company reported in its quarterly earnings call on January 30.
Ease the auditing process for respiratory providers
The HME industry met in Las Vegas for education and the latest in product development
Answers from industry experts
Technology is the key to preventing readmissions
How CPAP cross-platforms are transforming the sleep market for everyone in the care process